In apparent contrast to the data presented here, vemurafenib, a BRAFV600E inhibitor, was previously found to up-regulate IFN-mediated MHC II expression in A375 melanoma cells (Sapkota et al., 2013). The gene discussed is IFNA1; the disease is melanoma.